Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 82
Selected: 0
NCT IDTitle
NCT05584800Study of ZGGS18 in Patients With Advanced Solid Tumors
NCT04612699A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis
NCT06239298A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor
NCT04507659Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis
NCT04816123The Mass Balance and Biotransformation of [14C]Donafenib in Healthy Adult Man
NCT06938880Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
NCT06132243Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions
NCT04312594Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis
NCT05686629An Efficacy and Safety Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia
NCT05676242A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis
NCT05861128Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS)
NCT04503902Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma
NCT05255237Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
NCT07231445Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer
NCT04539639Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis
NCT06903377Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
NCT04964284Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer
NCT04971551A Study of Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.
NCT07142837Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors
NCT02645981Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma
NCT04402723Combination of Donafenib and Cytarabine/Daunorubicin in Relapsed AML
NCT06193148A Study to Evaluate the Effect of Jaktinib on QT/QTc Interval in Healthy Participants
NCT04445363A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata
NCT04851535Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.
NCT05688839A Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia
NCT05877664Study of ZG0895.HCl in Patients With Advanced Solid Tumors
NCT04866056Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
NCT05576909Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation
NCT06283719Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
NCT04605185Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma
NCT02870582Donafenib for Previously Treated Metastatic Colorectal Cancer
NCT06592638A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
NCT06372626Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.
NCT06440057Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.
NCT02698111Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma
NCT03607188Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer
NCT02870569Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer
NCT04472858A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors
NCT05702788Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)
NCT02229071Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma
NCT05864573Study of ZGGS15 in Patients With Advanced Solid Tumors
NCT05279001A Safety and Tolerability Study of Jaktinib
NCT06233292A Study of ZG005 in Patients With Advanced Solid Tumors
NCT02489201A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer
NCT07038096ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
NCT03314402The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers
NCT05861102Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)
NCT03611426Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy
NCT06883526Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma
NCT07080216Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer